logo oncology-news

Онкология  >  Новости онкологии

При финансовой поддержке logo MSD Oncology

Ribociclib-letrozole combo shows promise in ER+ ovarian, endometrial cancer

Patients with ER+ recurrent low-grade serous ovarian cancer derive most benefit.